CPX-351 works synergistically in combination with FLT3 inhibitors against AML with FLT3-ITD

被引：3
|
作者：
Edwards, David K.
Javidi-Sharifi, Nathalie
Rofelty, Angela
Gordon, Max
Roth-Carter, Riley
Tardi, Paul
Mayer, Lawrence
Tyner, Jeffrey W.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1087
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1087
引用
收藏
页数：2
相关论文
共 50 条
  • [31] RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML
    Cucchi, David G. J.
    Denys, Barbara
    Kaspers, Gertjan J. L.
    Janssen, Jeroen J. W. M.
    Ossenkoppele, Gert J.
    de Haas, Valerie
    Zwaan, C. Michel
    van den Heuvel-Eibrink, Marry M.
    Philippe, Jan
    Csikos, Tamas
    Kwidama, Zinia
    de Moerloose, Barbara
    de Bont, Eveline S. J. M.
    Lissenberg-Witte, Birgit I.
    Zweegman, Sonja
    Verwer, Femke
    Vandepoele, Karl
    Schuurhuis, Gerrit Jan
    Sonneveld, Edwin
    Cloos, Jacqueline
    BLOOD, 2018, 131 (22) : 2485 - 2489
  • [32] The effect of FLT3 gene expression in senescence and telomere length regulation in AML cells with FLT3-ITD mutation
    Hong, Jing Siou
    Yen, Jui Hung
    Wu, Chia Ling
    Chen, Pei Yi
    CANCER SCIENCE, 2025, 116 : 256 - 256
  • [33] Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
    Dan Xu
    Yishan Chen
    Ying Yang
    Zhao Yin
    Changfen Huang
    Qiang Wang
    Ling Jiang
    Xuejie Jiang
    Changxin Yin
    Qifa Liu
    Guopan Yu
    Journal of Translational Medicine, 20
  • [34] The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells
    Hospital, Marie-Anne
    Green, Alexa S.
    Lacombe, Catherine
    Mayeux, Patrick
    Bouscary, Didier
    Tamburini, Jerome
    BLOOD, 2012, 119 (07) : 1791 - 1792
  • [35] Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
    Xu, Dan
    Chen, Yishan
    Yang, Ying
    Yin, Zhao
    Huang, Changfen
    Wang, Qiang
    Jiang, Ling
    Jiang, Xuejie
    Yin, Changxin
    Liu, Qifa
    Yu, Guopan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [36] Current Approaches to Transplantation for FLT3-ITD AML
    Bradley D. Hunter
    Yi-Bin Chen
    Current Hematologic Malignancy Reports, 2020, 15 : 1 - 8
  • [37] KRX-101, a Novel FLT3 Inhibitor, Potently Active Against Resistant FLT3-ITD/FLT3-TKD Mutant AML in Vitro and In Vivo
    Sintim, Herman O.
    Aman, M. Javad
    Holtsberg, Frederick
    Emadi, Ashkan
    Lapidus, Rena G.
    BLOOD, 2018, 132
  • [38] Current Approaches to Transplantation for FLT3-ITD AML
    Hunter, Bradley D.
    Chen, Yi-Bin
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (01) : 1 - 8
  • [39] Combination of c-SRC and FLT3 Inhibitors Has An Additive Inhibitory Effect on FLT3 ITD but Not on FLT3 TKD Positive Cells
    Leischner, Hannes
    Grundler, Rebekka
    Albers, Corinna
    Illert, Anna Lena
    Goetze, Katharina
    Peschel, Christian
    Duyster, Justus
    BLOOD, 2010, 116 (21) : 1191 - 1191
  • [40] CPX-351 in FLT3-mutated acute myeloid leukemia
    Andrews, Claire
    Pullarkat, Vinod
    Recher, Christian
    FRONTIERS IN ONCOLOGY, 2023, 13
12345